Search Results - "SHIRLEY, J. T"

Refine Results
  1. 1
  2. 2
  3. 3

    Discovery of CP-199,330 and CP-199,331 : Two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicity by CHAMBERS, R. J, MARFAT, A, WATSON, J. W, ANTOGNOLI, G. W, CHENG, J. B, DAMON, D. B, KUPERMAN, A. V, LISTON, T. C, MEBUS, C, PILLAR, J. S, SHIRLEY, J. T

    Published in Bioorganic & medicinal chemistry letters (20-09-1999)
    “…CP-199,330 (3) and CP-199,331 (4) are cysLT1 receptor antagonists that are equipotent to marketed cysLT1 receptor antagonists zafirlukast and pranlukast, show…”
    Get full text
    Journal Article
  4. 4

    Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists by CHAMBERS, R. J, ANTOGNOLI, G. W, CHENG, J. B, KUPERMAN, A. V, LISTON, T. C, MARFAT, A, OWENS, B. S, PILLAR, J. S, SHIRLEY, J. T, WATSON, J. W

    Published in Bioorganic & medicinal chemistry letters (15-12-1998)
    “…A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor…”
    Get full text
    Journal Article
  5. 5

    Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid by Cheng, J B, Pillar, J S, Shirley, J T, Showell, H J, Watson, J W, Cohan, V L

    “…Eosinophil peroxidase (EPO) has been used previously to detect the number of eosinophils in the peritoneal exudate and bone marrow of mice. The present study…”
    Get more information
    Journal Article
  6. 6

    Development of new chromanol antagonists of leukotriene D4 by CHAMBERS, R. J, ANTOGNOLI, G. W, CHENG, J. B, MARFAT, A, PILLAR, J. S, SHIRLEY, J. T, WATSON, J. W

    Published in Bioorganic & medicinal chemistry letters (21-07-1998)
    “…By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical…”
    Get full text
    Journal Article
  7. 7

    Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes by Shirley, J T, Cheng, J B

    “…Pharmacological analysis of the effects of leukotriene D4 (LTD4) antagonists on contraction of guinea pig airway smooth muscle to leukotrienes reveals the…”
    Get more information
    Journal Article
  8. 8

    Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs by Cheng, J B, Pillar, J S, Conklyn, M J, Breslow, R, Shirley, J T, Showell, H J

    “…Lungs from guinea pigs passively sensitized with an affinity-purified IgG1 antibody produce both leukotriene (LT)D4 and thromboxane (Tx)B2 upon ex vivo antigen…”
    Get more information
    Journal Article
  9. 9

    N-carbamoyl analogs of zafirlukast: Potent receptor antagonists of leukotriene D4 by BROWN, M. F, MARFAT, A, PILLAR, J. S, SHIRLEY, J. T, WATSON, J. W, ANTOGNOLI, G, CHAMBERS, R. J, CHENG, J. B, DAMON, D. B, LISTON, T. E, MCGLYNN, M. A, O'SULLIVAN, S. P, OWENS, B. S

    Published in Bioorganic & medicinal chemistry letters (22-09-1998)
    “…Exploration of the indole nitrogen region of Zafirlukast (1) has uncovered a potent series of cysteinyl leukotriene D4 (LTD4) antagonists. These studies showed…”
    Get full text
    Journal Article
  10. 10

    Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase by Lowe, John A, Archer, Robert L, Chapin, Douglas S, Cheng, John B, Helweg, David, Johnson, Jonathan L, Koe, B. Kenneth, Lebel, Lorraine A, Moore, Peter F

    Published in Journal of medicinal chemistry (01-02-1991)
    “…A series of quinazolinediones and azaquinazolinediones is described which possess potent inhibitory activity toward the calcium-independent phosphodiesterase…”
    Get full text
    Journal Article
  11. 11

    Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-α by Chambers, R.J., Marfat, A., Cheng, J.B., Cohan, V.L., Damon, D.B., Duplantier, A.J., Hibbs, T.A., Jenkinson, T.H., Johnson, K.L., Kraus, K.G., Pettipher, E.R., Salter, E.D., Shirley, J.T., Umland, J.P.

    Published in Bioorganic & medicinal chemistry letters (18-03-1997)
    “…Tumor necrosis factor-α (TNF-α) has been implicated as a key mediator in the progression of rheumatoid arthritis. Inhibitors of phosphodiesterase IV (PDE IV)…”
    Get full text
    Journal Article
  12. 12

    A Preview of Augmented Reality as Pioneering Method in Education by Shirley, J.T. Preethy, Malathi, S.

    “…In Today's fast paced world, constant changes occur in everything around us especially technologies and this triggers the education sector to embrace the…”
    Get full text
    Conference Proceeding
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Development of new chromanol antagonists of leukotriene D 4 by Chambers, R.J., Antognoli, G.W., Cheng, J.B., Marfat, A., Pillar, J.S., Shirley, J.T., Watson, J.W.

    Published in Bioorganic & medicinal chemistry letters (21-07-1998)
    “…By addressing the issues of potency and metabolism in 3, a new series of LTD 4 antagonists represented by (+)- 26 was developed which is equipotent to clinical…”
    Get full text
    Journal Article
  18. 18
  19. 19

    N-carbamoyl analogs of zafirlukast: Potent receptor antagonists of leukotriene D 4 by Brown, Matthew F., Marfat, Anthony, Antognoli, Gerard, Chambers, Robert J., Cheng, John B., Damon, David B., Liston, Theodore E., McGlynn, Molly A., O'Sullivan, Stacie P., Owens, Brian S., Pillar, Joann S., Shirley, John T., Watson, John W.

    Published in Bioorganic & medicinal chemistry letters (22-09-1998)
    “…Exploration of the indole nitrogen region of Zafirlukast ( 1) has uncovered a potent series of cysteinyl leukotriene D 4 (LTD 4) antagonists. These studies…”
    Get full text
    Journal Article
  20. 20